The secretory Na-K-Cl cotransporter, NKCC1, is activated by secretagogues through a phosphorylation-dependent mechanism. We find a phosphorylation stoichiometry of 3.0+0.4 phosphorylated residues per NKCC1 protein harvested from shark rectal gland tubules maximally stimulated with forskolin and calyculin A, showing that at least three sites on the cotransporter are phosphorylated upon stimulation. Three phosphoacceptor sites are identified on the N-terminal domain of the protein, at T 184 , T 189 , and T 202 , using HPLC and MALDI-TOF MS to analyze tryptic fragments of radiolabeled cotransporter. None of these residues occurs in the context of strong consensus sites for known S/T kinases. The threonines and the surrounding amino acids are highly conserved between NKCC1 and NKCC2 and similarities are also present in the Na-Cl cotransporter (NCC, TSC). This strongly suggests that the phosphoregulatory mechanism is conserved among isoforms. Through expression of sNKCC1 mutants in HEK-293 cells, the residue T 189 is found to be necessary for activation of the protein, while phosphorylation at T 184 and T 202 are modulatory but not required. In conjunction with the recent finding that protein phosphatase 1 binds to residues 107-112 in the sNKCC1 sequence, these results demonstrate that the N-terminus of NKCC1 constitutes a phospho-regulatory domain of the transporter.
INTRODUCTION
The secretory Na-K-Cl (NKCC1) cotransporter is a major pathway for net influx of Cl -in many cells (1, 2) . Along with the absorptive Na-K-Cl cotransporter (NKCC2) and the thiazide-sensitive Na-Cl transporter (NCC or TSC), NKCC1 belongs to the Nacoupled branch of the cation chloride cotransporter family; this family also includes the K-Cl transporters (KCC's) (3) and two other major branches of putative transporters including hCIP (4) , and SLC12-8 (Genbank entry AAK94307) whose transport functions are yet unknown. These proteins are all predicted to have 12 transmembrane spanning domains that are responsible for ion transport properties (5) and large cytoplasmic N-and C-termini that are candidates for regulatory domains. NKCC1 is expressed in many cell types and is involved in the regulation of both cell volume and intracellular Cl -concentration (2, 6 ). This isoform is also a major component of the basolateral membrane of secretory cells, mediating Cl -influx, the first step in the transepithelial movement of Cl -4 response to forskolin or hypertonic stress and the N-terminus of NKCC1 has been shown to be the locus of at least some of the phosphoregulatory sites (7, 11) . Although, in many cells, PKA agonists effect an increase in Na-K-Cl cotransporter activity, the cotransporter does not appear to be directly phosphorylated by PKA (12,13). Current evidence indicates that the principal regulatory pathway involves PKA-mediated stimulation of apical Cl -channels and subsequent phosphorylation of NKCC1 in response to decreases in cell Cl -and volume by an as yet unknown kinase (12).
The salt-secreting rectal gland of the shark has proven to be an excellent physiological and biochemical model system for the study of fluid secretion. In this study we exploit the rectal gland epithelium to examine phosphorylation sites on NKCC1 and demonstrate that the N-terminus functions as a regulatory phosphorylation domain. Of the three phosphoacceptors identified, T 189 is shown to be critical for activation, while T 184 and T 202 are necessary for optimum sensitivity and full activation of transport.
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EXPERIMENTAL PROCEDURES
Materials and reagents. Dogfish sharks were obtained by net off the coast of Mt.
Desert Island, ME, and rectal glands were removed after sacrificing the animals. As shown in Fig. 1a , the enzymatic incorporation of 32 PO 4 into cellular ATP and ADP is linear through 60 minutes. The fraction of label in the γ position decreases somewhat over time (Fig. 1b) , as an increasing amount of radioactivity is incorporated into the β position of ATP. (Fig. 7 below) , the solutions were supplemented with 50 µM furosemide to prevent transporter specific alterations in ionic balance ( (15)). "Low Cl -hypotonic medium" (also termed here "3Cl/2") refers to the 3 mM Cl -solution diluted two-fold with water. "0Na-0K-130Cl hypertonic medium" contained N-methyl glucamine to replace all of the Na and K/Rb in the basic solution, and additional 130 mM N-methyl glucamine gluconate to make the solution approximately 2x hypertonic. "High K + medium" was basic medium with additional 10 mM K + .
The relative amount of NKCC (wild type and mutants) was determined in most experiments by dot blotting with J3 antibody, a monoclonal antibody specific for sNKCC1 (16) . Cells from single wells of the 96-well flux plate were solubilized in 100
µl of SDS sample buffer and serially diluted at a 1:5 ratio 4 times; 20 µl aliquots of each dilution were blotted in a 96-well blotter; and NKCC was detected with J4 antibody, Pierce West Dura luminescent reagent, and a cooled CCD camera. Additionally, total protein was determined in individual wells using the Biorad DC assay and a 96-well plate reader after solubilizing cells in 50 µl of 1%SDS (3 -12 wells for each line on a plate).
On a routine basis the uniformity of cells in the 96-well plate was checked by visual inspection of the cellular monolayer following the flux experiment.
Immunofluorescence analysis. Visualization of sNKCC in transfected HEK cells was performed as previously described (6) . Briefly, cells were fixed in the culture dish with PLP fixative, scraped from the dish, and pelleted at low speed; semi-thin cryosections were cut from cryopreserved specimens. J4 (anti-shark NKCC) monoclonal antibody was used to detect sNKCC1 with an Alexa 488 secondary anti-mouse secondary
RESULTS
We determined the stoichiometry of NKCC1 phosphorylation in rectal gland tubule cells by measuring the number of moles [ 32 P]-phosphate incorporated per mole of Na-K-Cl cotransporter during a 10 min incubation period with forskolin and calyculin A.
In the present study, an average of 3.0+0.4 phosphates per mole cotransporter was determined in six experiments using the determined specific activity of γ − label in cellular ATP (see Fig. 1 , above). This value is close to that reported by Lytle for cotransporter phosphorylation in avian red cells (17); as discussed below, the determination of stoichiometry represents a minimum estimate of the number of phosphoacceptor sites.
We have noted that there is little incorporation of label into the cotransporter under resting conditions: in numerous experiments (data not shown) and as previously reported (7) less than 20% of [ 32 P]-label is incorporated in the absence of stimulatory agents, and we have been unable to isolate individual peaks of radioactivity when control samples are digested with trypsin and peptides are separated by HPLC. A stoichiometric relationship greater than 1 for phosphate incorporation into NKCC1 is consistent with a causal relationship between cotransporter phosphorylation and increased activity.
(fig 2 here).
To identify individual phosphorylated residues in NKCC1, labeled cotransporter protein was subjected to exhaustive trypsin digestion and separated by HPLC. The labeled Na-K-Cl cotransporter elution profile showed more than 15 fractions with levels of incorporation above background (Fig. 2) . As shown below, this profile alone does not
give a useful estimate of the number of phosphorylation sites on the cotransporter protein since incomplete tryptic digestion can give rise to many partial cleavage products and by guest on September 1, 2017
because mono-and di-phosphorylated peptides will run with different mobility on the column. Using MALDI-TOF spectroscopy, phosphorylated peptides were identified by an appropriate mass shift in reflectron mode and/or by alkaline phosphatase digestion to remove phosphates from the peptides. The sequences of each peptide in the labeled fraction were ultimately confirmed by Edman degradation. We were able to positively identify 4 of the major phosphorylated peptides from the fractions with measurable levels of 32 P incorporation and to match these with regions of the sNKCC1 protein (other fractions did not yield useful MALDI data). Table 1 Two major peptides appeared in the linear mode spectrum of fraction 61, one of mass 1105, the other of 1489 (Fig. 3A. ). Based on mass alone, the 1105 peak best matches the non-phosphoacceptor peptide 1105 MKEEEPWR 1112 in the COOH domain of the sNKCC1 sequence. With the mass resolution available in this instrument, the 1489 peak had a possible match with three predicted phosphopeptides: a diphosphorylated 184 TFGHNTIDAVPR 195 and a mono-tyrosine phosphorylated 826 AFYAPVYAEDLR 837 .
To determine whether these peptides were phosphorylated, fraction 61 was treated with alkaline phosphatase, and again analyzed by MALDI (Fig. 3B) In further MS analysis, the monophosphorylated form of the 184 TFGHNTIDAVPR 195 peptide was found to constitute the radioactivity in HPLC fraction 67 (not shown). It was not determined which of the two phosphoacceptors was phosphorylated in this fraction -most likely the peak contains a mixture of the two potential monophosphorylated peptides. The T189 phosphoacceptor site has been previously identified by Lytle and Forbush in a trypsin/CnBr digest fragment, presumably corresponding to fraction 67 (7) . In that study, it was not possible to identify T 184 as a phosphoacceptor because of high background in Edman sequencing of the initial residue.
(fig 4 here).
MS analysis of HPLC fraction 55 resulted in the identification of a second peptide with a novel phosphorylation site. In linear mode (Fig. 4a) , two major peptides appear in the fraction, one at 1751 and the other at 923. The 923 peak is insensitive to alkaline phosphatase ( Fig. 4b ) and does not shift under conditions of limited post source decay.
The 1751 peak is shifted by -83 Da in the spectra of alkaline phosphatase treated samples and by -98 Da in the reflectron spectrum (Fig. 4c) . In both cases, the shifts are consistent with loss of a single phosphate species from a serine or threonine residue on the peptide.
Edman degradation showed that there were three peptides in the sample, one, an IgG contaminant, another VYTMGPPR of mass 923, and the third corresponding to sequence
Only a single threonine occurs on this peptide, and the gap in the sequencing data is consistent with it being the phosphoacceptor. The product of complete digest, 201 HTVAQLGEK 209 , was also identified as the phosphorylated component in Fraction 40
(data not shown.).
(fig 5 here).
In order to test the functional significance of these phosphorylation sites in 
(fig 6 here).
NKCC1 is activated under conditions in which the cell is depleted of cell chloride, and we have routinely used low Cl -preincubation to stimulate transport in HEK-293 cells (5, 19, 20) . As illustrated in Fig. 6 , replacing the T 189 phosphoacceptor with alanine resulted in a mutant with little detectable cotransporter flux, presumably because the mutation prevents the activation of the cotransporter by a low Cl -stimulus. In fact, as discussed further below, these mutants actually have lower transport activity than the native HEK-293 cells (21) and the lines transfected with vector-alone --that is, the mutant cotransporters exert a dominant negative effect.
In some, but not all, proteins regulated by phosphorylation, the substitution of a phosphoacceptor serine or threonine with an acidic residue can mimic the effect of phosphorylation at that locus (22, 23) . However, for T 189 of the Na-K-Cl cotransporter, a replacement with aspartate did not restore activity. The T 189 D mutant shows neither a constitutive activation nor the ability to be activated in response to the stimulus (the latter is shown in Fig. 6 ). Similarly, a triple threonine to glutamate mutation of the identified phosphoacceptor sites resulted in a non-activatable cotransporter (Fig. 6 ).
We have also altered the T 189 site to meet the consensus criterion for PKA phosphorylation, by replacement of the sequence 186 GHNT with 186 RRNT ("PKA-1") and in another mutant, by 186 RKNT ("PKA-2"). As with the other T 189 mutations, these replacements eliminated the transport function of the cotransporter (Fig. 6) , and there was no evidence of an increase in activity by elevation of cAMP levels using 50 µM forskolin (data not shown; forskolin actually produces some inhibition of 86 Rb influx in HEK cells -see Fig. 8 , below). We presume that either the structural context of T 189 renders it inaccessible to PKA, or that the altered context of the site renders it ineffective in bringing about the necessary cotransporter conformational change.
(fig 7 here).
In In the region immediately upstream of T 184 , there are many potential phosphoacceptor serines and threonines, some of which (eg. T 177 -T 179 ) are in a very similar context to T 184 /T 189 . Speculating that these residues might also be involved in activation of the transporter, we prepared a T 177 A/T 179 A mutant. In fact, as illustrated in Fig. 7B (lower panel), the behavior of this construct is very close to that of wild type NKCC1, with a small tendency for the mutant to be less activated by a given stimulus.
( fig. 8 here) . ( fig. 9 here) .
In the course of these experiments we found that stable cell lines containing T 189 mutants exhibited maximal 86 Rb influx that was generally lower than that of vectortransfected cell lines; this phenomenon is particularly evident at intermediate levels of cotransporter activation (Fig. 9 ). This dominant-negative effect of inactive NKCCs has been noted in other mutagenesis studies in our laboratory (5) and is also seen with a truncation variant of NKCC2 (24), in inactive mutants of KCC1 (25) Indeed, the isolation of the peptide containing T 184 and T 189 as a monophosphorylated species in fraction 67 illustrates that not every acceptor site is fully phosphorylated in our experimental samples. With this considered, we must defer to the measurement of 5:1 stoichiometry for NKCC1 in duck erythrocyte cotransporter maximally stimulated by hyperosmotic stress (17) , supporting an estimate of at least 5 phosphoacceptor sites in NKCC1. It is also true that while we have identified three threonine residues, previous work has demonstrated the presence of phosphoserine as well as well as phosphothreonine in activated NKCC1 from both shark and avian sources (7, 17) .
( fig. 10 here) .
We suggest that the region just N-terminal to T 184 is a likely candidate for regulatory phosphorylation by the same kinase. This region is highly conserved between shark and human ( Fig. 10 ) and it contains a number of threonines and serines in a context very similar to that of T 184 /T 189 . In an initial test of two of these potential phosphoacceptors we found that a T 177 A/T 179 A mutant is almost indistinguishable from wild type NKCC1 (Fig. 7B) , but there are a 16 more candidate residues in this region, of which 7 are conserved between shark and human. In biochemical analysis, the residues upstream of T 184 would be found in an 8 kDa tryptic fragment (residues 108-183);
possibly this large fragment is present in HPLC fractions 80-92 on which we were unable to obtain useful MS data.
Importantly, the identified phosphoacceptors T 184 , T 189 , and T 202 all occur in a highly conserved region of the N-terminus of NKCC (Fig. 10) . The sequences flanking these phosphorylation sites are almost identical between shark and human NKCC1
(similarity indicated by color in Fig. 10 ) arguing for an essential regulatory role of this domain. The current finding of three phosphoacceptors in the N-terminus of NKCC1
extends our earlier observation that T 189 is phosphorylated (7), and it is fully consistent with the work of Kurihara et al. (11) that all of the regulatory phosphorylation of NKCC1 in rat parotid gland is found in the N-terminal cytoplasmic domain. The identified phosphoregulatory region is very well conserved between NKCC1 and NKCC2, with only two amino acid differences occurring in the region corresponding to sNKCC1 residues 181-194. The fact that the domain has been conserved in NKCC2 as well as in NKCC1 argues that both isoforms are activated by essentially the same mechanism, and recent data from our laboratory strongly supports this hypothesis (26); alternative mechanisms for regulation of NKCC2 have also been suggested (24) . Although there is less similarity than between the two NKCC isoforms, the Na-Cl cotransporter (NCC)
retains potential phosphoacceptors corresponding to T 184 , T 189 , and T 202 in a very similar context. Therefore we speculate that NCC is also regulated largely by phosphoacceptors in its N-terminus.
The data presented here add to a growing body of evidence that the N-terminus of In evaluating the results of mutations at T 184 and T 202 , we should consider the possibility that, rather than having a direct mechanistic effect, the alteration at these sites changes the sensitivity profile by decreasing phosphorylation at T 189 . While it is generally difficult to examine this experimentally, the utilization of the αphospho-NKCC antibody has allowed us to investigate the result of the T 202 E mutation. As described in the accompanying paper (29), the changes in sensitivity seen in the activation of Peptide elution profile of tryptic digest of NKCC1, separated on a C18 HPLC column. B.
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